JT Stratford LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.56M | Buy |
197,874
+30,833
| +18% | +$821K | 0.71% | 29 |
|
|
2025
Q4 | $4.16M | Buy |
167,041
+96,671
| +137% | +$2.44M | 0.53% | 37 |
|
|
2025
Q3 | $1.79M | Buy |
70,370
+52,849
| +302% | +$1.3M | 0.24% | 91 |
|
|
2025
Q2 | $425K | Buy |
17,521
+7,359
| +72% | +$172K | 0.06% | 205 |
|
|
2025
Q1 | $258K | Sell |
10,162
-14,191
| -58% | -$371K | 0.05% | 244 |
|
|
2024
Q4 | $646K | Buy |
24,353
+7,240
| +42% | +$196K | 0.11% | 176 |
|
|
2024
Q3 | $495K | Sell |
17,113
-108
| -0.6% | -$3.15K | 0.08% | 205 |
|
|
2024
Q2 | $482K | Sell |
17,221
-9,735
| -36% | -$268K | 0.09% | 198 |
|
|
2024
Q1 | $748K | Sell |
26,956
-22,391
| -45% | -$621K | 0.15% | 158 |
|
|
2023
Q4 | $1.42M | Sell |
49,347
-6,495
| -12% | -$196K | 0.32% | 77 |
|
|
2023
Q3 | $1.85M | Sell |
55,842
-37,798
| -40% | -$1.34M | 0.48% | 50 |
|
|
2023
Q2 | $3.43M | Buy |
93,640
+15,475
| +20% | +$602K | 0.92% | 20 |
|
|
2023
Q1 | $3.19M | Buy |
78,165
+6,224
| +9% | +$269K | 0.92% | 18 |
|
|
2022
Q4 | $3.69M | Buy |
71,941
+1,105
| +2% | +$53K | 1.18% | 16 |
|
|
2022
Q3 | $3.1M | Sell |
70,836
-2,112
| -3% | -$103K | 1.1% | 19 |
|
|
2022
Q2 | $3.83M | Sell |
72,948
-3,449
| -5% | -$176K | 1.21% | 19 |
|
|
2022
Q1 | $3.96M | Sell |
76,397
-12,213
| -14% | -$634K | 1.16% | 19 |
|
|
2021
Q4 | $5.23M | Buy |
88,610
+913
| +1% | +$45.2K | 1.43% | 15 |
|
|
2021
Q3 | $3.77M | Buy |
87,697
+43,986
| +101% | +$1.95M | 1.16% | 18 |
|
|
2021
Q2 | $1.71M | Sell |
43,711
-1,495
| -3% | -$58.1K | 0.55% | 47 |
|
|
2021
Q1 | $1.64M | Buy |
45,206
+2,599
| +6% | +$92.3K | 0.58% | 44 |
|
|
2020
Q4 | $1.57M | Buy |
42,607
+5,355
| +14% | +$196K | 0.59% | 45 |
|
|
2020
Q3 | $1.3M | Sell |
37,252
-3,983
| -10% | -$140K | 0.56% | 48 |
|
|
2020
Q2 | $1.28M | Buy |
41,235
+6,056
| +17% | +$206K | 0.66% | 53 |
|
|
2020
Q1 | $1.09M | Buy |
35,179
+13,978
| +66% | +$476K | 0.67% | 51 |
|
|
2019
Q4 | $788K | Sell |
21,201
-3,173
| -13% | -$113K | 0.36% | 77 |
|
|
2019
Q3 | $831K | Buy |
24,374
+6,538
| +37% | +$238K | 0.47% | 66 |
|
|
2019
Q2 | $733K | Sell |
17,836
-5,751
| -24% | -$228K | 0.41% | 64 |
|
|
2019
Q1 | $950K | Buy |
23,587
+238
| +1% | +$9.53K | 0.55% | 53 |
|
|
2018
Q4 | $967K | Sell |
23,349
-1,579
| -6% | -$65.5K | 0.64% | 50 |
|
|
2018
Q3 | $1.04M | Buy |
24,928
+3,268
| +15% | +$126K | 0.6% | 50 |
|
|
2018
Q2 | $746K | Buy |
21,660
+626
| +3% | +$21.4K | 0.46% | 61 |
|
|
2018
Q1 | $708K | Buy |
21,034
+988
| +5% | +$34K | 0.44% | 62 |
|
|
2017
Q4 | $689K | Sell |
20,046
-1,011
| -5% | -$34.5K | 0.45% | 58 |
|
|
2017
Q3 | $713K | Sell |
21,057
-2,003
| -9% | -$64.4K | 0.46% | 55 |
|
|
2017
Q2 | $735K | Sell |
23,060
-2,557
| -10% | -$80.6K | 0.52% | 48 |
|
|
2017
Q1 | $831K | Sell |
25,617
-3,353
| -12% | -$106K | 0.62% | 47 |
|
|
2016
Q4 | $893K | Buy |
+28,970
| New | +$884K | 0.75% | 44 |
|
Other funds holding PFE
VCM
VPM
JT Stratford LLC's PFE Position: Q1 2026 in Review
JT Stratford LLC increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $821K and bringing the position to 197,874 shares worth $5.56M. The position accounts for 0.71% of the portfolio, ranked #29.
JT Stratford LLC first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- JT Stratford LLC held 197,874 shares of Pfizer worth $5.56M as of Q1 2026.
- JT Stratford LLC bought 30,833 Pfizer shares in Q1 2026, an estimated $821K.
- Pfizer made up 0.71% of JT Stratford LLC's portfolio in Q1 2026, its #29 holding.
- JT Stratford LLC first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on JT Stratford LLC's 13F filing for Q1 2026, filed 15 May 2026.